Among GBM, IDH-WT tumors, CR-mut was associated with worse OS with a median difference of 2.01 months (median of 13.4 months in CR-mut vs 15.4 months in CR-WT, HR: 1.185, 95% CI: 1.056–1.329, P = .004; Figure 5A). The gene discussed is IDH1; the disease is glioblastoma.